Table 4.

Comparison of effectiveness between the two arms.

	Preemptive (n = 30)	Controls (n = 29)	P
Rates (%) of PUQE ≥ 11 in first 3 weeks of NVP	4 (15.4%) (n = 26)	9 (39.13%) (n = 23)	P < 0.04
AUC of PUQE × Time in 1st trimester (SD)	6.38 (1.58) (n = 25)	6.11 (2.24) (n = 22)	NS
NVP resolved before labor	18/23 (78.2%)	11/22 (50%)	<0.002
Gest. age when NVP resolved (median wk)	26	33	0.18
Distribution of HG in previous versus this pregnancy*
HG in previous pregnancy	19	11	0.047*
HG in present pregnancy	6	6
Mean daily dose of Diclectin {mg/kg (SD)}	0.65 (0.23)	0.56 (0.24)	0.2
Mean gestational age (in weeks) when NVP symptoms began (SD)	5.30 (1.02)	5.45 (1.88)
Mean start of preemptive therapy (SD)	3.8 (0.98)

AUC = Area under the curve.